Role of inflammatory cell RAGE in collateral vessel formation
Role of inflammatory cell RAGE in collateral vessel formation
批准号:
7788446
负责人:
William Robert Taylor
金额:
$40.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-13 至 2014-07-31
关键词:
Advanced Glycosylation End ProductsAdverse effectsAnatomyAtherosclerosisBindingBiological AssayBlood VesselsBlood flowCardiovascular systemCell Culture TechniquesCell physiologyCellsComplications of Diabetes MellitusCoupledDataDevelopmentDiabetes MellitusDiabetic AngiopathiesEtiologyExhibitsGene ExpressionGoalsGrowthHistologyHumanImpairmentIn VitroInflammationInflammatoryInflammatory ResponseIschemiaLaboratoriesLimb structureMediatingModelingMorbidity - disease rateMusObstructionPathologyPhysiologicalPlayProcessProductionPublic HealthReactive Oxygen SpeciesReceptor CellRelative (related person)RoleRunningSeriesSignal TransductionSmall Interfering RNAT-Cell ActivationT-LymphocyteTherapeuticUnited StatesVascular Diseasescell typediabeticdiabetic patientinsightmacrophagemonocytemortalitynanoparticlenovel strategiesoverexpressionpre-clinicalreceptorreceptor expression
中文摘要
在美国,糖尿病是一个爆炸性的重大公共卫生问题,直接影响心血管疾病的发病率和死亡率。这些破坏性心血管并发症的一个主要原因是糖尿病患者侧支血管发育受损。功能侧支血管的形成是人类对血流阻塞的主要适应机制。在这个项目中,我们将探讨晚期糖基化终产物和晚期糖基化终产物特异性受体(RAGE)在抑制侧支血管形成中的作用。我们已经开发了令人兴奋的初步数据,显示晚期糖基化终产物显著抑制侧支血管的形成。此外,我们
英文摘要
Diabetes in the United States today is an explosive major public health issue that directly impacts cardiovascular morbidity and mortality. One major reason for these devastating cardiovascular complications is that diabetics exhibit impaired collateral vessel development. Formation of functional collateral blood vessels is the primary adaptive mechanism in humans to blood flow obstruction. In this project we will explore the role of advanced glycation end products and the specific receptor for advanced glycation end products (RAGE) in inhibition of collateral blood vessel formation. We have developed exciting preliminary data showing that advanced glycation end products dramatically inhibit collateral vessel formation. Moreover, we
have presented preliminary data that demonstrate a central role for RAGE signaling in monocytes in this process. The proposed studies will first examine the overall role of RAGE in inhibiting collateral vessel formation. Subsequent aims will study the specific contributions of RAGE in monocytes and T cells as these two inflammatory cells types have been shown by us and others to be critical for the formation of collateral blood vessels. Additional studies will examine the role of reactive oxygen species as crucial signaling intermediates in RAGE signal transduction in both monocytes and T cells. Through these studies, we will
develop a comprehensive and critical assessment of the role of RAGE signaling in inflammatory cells and the subsequent impact on collateral vessel formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HOWARD UNIVERSITY GENERAL CLINICAL RESEARCH CENTER
-
批准号:8167000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:William Robert Taylor
-
依托单位:
Biology, Biomechanics and Atherosclerosis
-
批准号:7822529
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:7731048
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:9271227
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:8935386
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:8088112
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:7915248
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:9100846
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:8296360
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
-
批准号:7899832
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7952042
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
-
批准号:7682311
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
-
批准号:8116635
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7716577
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
IRPG (NOVEL PHENOTYPES)
-
批准号:7607806
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
MALT LIQUOR
-
批准号:7607808
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
Vascular specific ACE expression and atherosclerosis
-
批准号:7409084
-
项目类别:
-
资助金额:$48.4万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7606883
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2006
-
负责人:William Robert Taylor
-
依托单位:
IRPG (NOVEL PHENOTYPES)
-
批准号:7378661
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2006
-
负责人:William Robert Taylor
-
依托单位:
MALT LIQUOR
-
批准号:7378687
-
项目类别:
-
资助金额:$0.93万
-
财政年份:2006
-
负责人:William Robert Taylor
-
依托单位:
海外基金